Note*: This report requires 7-10 business days to complete.
DelveInsight’s Liver Cirrhosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Liver Cirrhosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Liver Cirrhosis till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Liver Cirrhosis market.
• Identifying patient populations in the global “Liver Cirrhosismarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Liver Cirrhosis therapeutics in each of the markets covered.
• To understand the future market competition in the global Liver Cirrhosis therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Liver Cirrhosis for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Liver Cirrhosis overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Liver Cirrhosis Market
• Global Epidemiology of Liver Cirrhosis Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Liver Cirrhosis Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Liver Cirrhosis (2013-2023)
• Table 7: Liver Cirrhosis Global Market (USD Millions), (2013-2015)
• Table 8: Liver Cirrhosis Global Market (USD Millions), (2016-2023)
• Table 9: Liver Cirrhosis US Market (USD Millions), (2013-2015)
• Table 10: Liver Cirrhosis US Market (USD Millions), (2016-2023)
• Table 11: Liver Cirrhosis Germany Market (USD Millions), (2013-2015)
• Table 12: Liver Cirrhosis Germany Market (USD Millions), (2016-2023)
• Table 13: Liver Cirrhosis United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Liver Cirrhosis United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Liver Cirrhosis France Market (USD Millions), (2013-2015)
• Table 16: Liver Cirrhosis France Market (USD Millions), (2016-2023)
• Table 17: Liver Cirrhosis Italy Market (USD Millions), (2013-2015)
• Table 18: Liver Cirrhosis Italy Market (USD Millions), (2016-2023)
• Table 19: Liver Cirrhosis Spain Market (USD Millions), (2013-2015)
• Table 20: Liver Cirrhosis Spain Market (USD Millions), (2016-2023)
• Table 21: Liver Cirrhosis Japan Market (USD Millions), (2013-2015)
• Table 22: Liver Cirrhosis Japan Market (USD Millions), (2016-2023)
• Table 23: Liver Cirrhosis ROW Market (USD Millions), (2013-2015)
• Table 24: Liver Cirrhosis ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Liver Cirrhosis Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Liver Cirrhosis (2013-2023)
• Figure 3: Liver Cirrhosis Global Market (USD Millions), (2013-2015)
• Figure 4: Liver Cirrhosis Global Market (USD Millions), (2016-2023)
• Figure 5: Liver Cirrhosis US Market (USD Millions), (2013-2015)
• Figure 6: Liver Cirrhosis US Market (USD Millions), (2016-2023)
• Figure 7: Liver Cirrhosis Germany Market (USD Millions), (2013-2015)
• Figure 8: Liver Cirrhosis Germany Market (USD Millions), (2016-2023)
• Figure 9: Liver Cirrhosis United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Liver Cirrhosis United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Liver Cirrhosis France Market (USD Millions), (2013-2015)
• Figure 12: Liver Cirrhosis France Market (USD Millions), (2016-2023)
• Figure 13: Liver Cirrhosis Italy Market (USD Millions), (2013-2015)
• Figure 14: Liver Cirrhosis Italy Market (USD Millions), (2016-2023)
• Figure 15: Liver Cirrhosis Spain Market (USD Millions), (2013-2015)
• Figure 16: Liver Cirrhosis Spain Market (USD Millions), (2016-2023)
• Figure 17: Liver Cirrhosis Japan Market (USD Millions), (2013-2015)
• Figure 18: Liver Cirrhosis Japan Market (USD Millions), (2015-2023)
• Figure 19: Liver Cirrhosis ROW Market (USD Millions), (2013-2015)
• Figure 20: Liver Cirrhosis ROW Market (USD Millions), (2016-2023)
• Conatus Pharmaceuticals Inc.
• Digna Biotech S.L.
• Galectin Therapeutics Inc.
• Gilead Sciences Inc.
• GNI Group Ltd.
• Human Stem Cells Institute
• INVENT Pharmaceuticals Inc.
• Nimbus Therapeutics LLC
• Pacific Therapeutics Ltd.
• PharmaIN Corporation
• Pharmicell Co. Ltd.
• S-Evans Biosciences Inc.
• Stelic Institute & Co. Inc.
• Stempeutics Research Private Limited
